Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(5):372-374; doi:10.1093/jnci/92.5.372
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Beidler, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beidler, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 5, 372-374, March 1, 2000
© 2000 Oxford University Press

NEWS

Cancer Treatment During Pregnancy: There’s Strength in Numbers for Researchers

Nora Beidler

Fortunately for patients, a cancer diagnosis during pregnancy is rare. For researchers, the rarity of the combination makes for difficult research, and gathering cases to examine becomes the initial challenge. Recently, the Motherisk program at the Hospital for Sick Children in Toronto, Canada, has begun an international registry of cases of cancer in pregnancy to contribute to this literature.

"We decided that since the combination of cancer and pregnancy is quite a rare combination, the only way that we could collect data was the Web and the Internet," said Motherisk’s Michael Lishner, M.D., co-director of Motherisk’s Consortium of Cancer in Pregnancy Evidence (CCoPE).

Lishner and his staff started . . . [Full Text of this Article]

A Rare Occurrence

Teratogenesis

Registries Available


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?